Related Party |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Related Party Transactions [Abstract] | |
| Related Party | Note 3 – Related Party In October 2023, the Company entered into the Option, License and Collaboration Agreement, as amended (the Gilead Collaboration Agreement), and a Common Stock Purchase Agreement and an Investor Rights Agreement (collectively, the Gilead Equity Agreements) with Gilead. Following the Company entering into the Gilead Equity Agreements, and as of June 30, 2026, Gilead is considered a related party based on its ownership of the Company's common stock. In May 2026, Gilead purchased 471,698 shares of the Company's common stock in the underwritten offering at a purchase price of $26.50 per share, resulting in aggregate gross proceeds to the Company of approximately $12.5 million (see Note 6 - Stockholders' Equity). As of June 30, 2026, the Company recorded $0.8 million in accounts receivable from collaboration on the condensed consolidated balance sheet for reimbursable costs incurred under the Gilead Collaboration Agreement. The Company recognized $13.4 million and $9.6 million of collaboration revenue under the Gilead Collaboration Agreement during the three months ended June 30, 2026 and 2025, respectively. The Company recognized $21.6 million and $19.0 million of collaboration revenue under the Gilead Collaboration Agreement during the six months ended June 30, 2026 and 2025, respectively. See Note 8 - Collaboration Agreement for additional details. |